search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
NEW BBI SCANNER DELIVERS STEP CHANGE IN PRESSURE INJURY PREVENTION


• The next generation of a unique risk assessment device for Pressure Injury/Pressure Ulcer (PI/PU) prevention is launched in the UK


• Cutting edge technology delivering 90% (weighted) reduction in Pressure Injury/Pressure Ulcer incidence


• 76% of UK adults know somebody who has suffered from a Pressure Injury/Ulcer


B


BI (Europe) Ltd, the pioneer in biometric-sensor based medical devices, has launched its ProvizioTM SEM Scanner: the first hand-held,


wireless PI/PU risk assessment device with data transfer capabilities. By digitally enhancing the existing care pathway across all healthcare settings, BBI is creating a new paradigm for PI/PU prevention. At the same time BBI highlights the potential enormity of this problem in the UK, with 76% of adults knowing somebody who has suffered from a PI/PU. The new ProvizioTM SEM Scanner is the only SEM


Scanner that acts as an adjunct to routine clinical skin assessment and provides enhanced insight and risk identification five days earlier than visual skin assessment. With its intuitive user interface, the new device is now even easier to use, scan, read, interpret and take action based on real-time results. The ProvizioTM SEM Scanner has, in preliminary laboratory testing, shown the same precision as BBI’s current SEM Scanner 200 model which has been in clinical practice in Europe since 2014. Martin Burns, CEO of BBI says “PI/PUs are common


in all healthcare settings and are an underappreciated public health issue. Where our SEM Scanner is in use, it results in a 90% (weighted) reduction in hospital acquired PI/PUs in acute care sites. We believe our Provizio™ SEM Scanner will encourage even more adoption of this technology and allow health care professionals to successfully manage the problem.” The intelligent technology, designed in collaboration


with healthcare professionals (HCPs) and researchers, supports targeted PI/PU incidence reduction in all challenging healthcare environments. The technology identifies Biocapacitance of soft tissues which is described as a biophysical marker. Analysis from the Centre for Economics and Business


Research (Cebr) estimates that more than three quarters (76%) of UK adults know somebody who has suffered from a PI/PU, be they a friend, family member, or colleague. Commenting on this statistic, Martin Burns says “PI/PUs remain a hidden problem. People tend to assume that it is only the elderly or wheelchair users who experience a PI/PU, but they are wrong. We recently spoke to a 49-year-old woman who went in for a double mastectomy following breast cancer, who suffered from


two category 3 PI/PUs.” The ProvizioTM SEM Scanner offers the following key


benefits:


Real-time data The device scans and collects patient data in real-


time, site-by-site and patient-by-patient. When placed in the Provizio™ Charging Hub, the collected data automatically transfers to the comprehensive Gateway Dashboard for patient, ward and facility management purposes. As all data is collected and stored in digital format, managing and reporting is easier and faster. HCPs are able to input patient ID information to facilitate additional data knowledge and interpretation.


Objective PI/PU risk alerts The Provizio™ SEM Scanner is designed to rapidly


and easily scan anatomically-specific areas of the body to identify increased risk of developing PI/PUs. These objective delta readings and integrated, seamless data management, help empower HCPs by earlier identification of increased PI/PU risk allowing anatomically targeted interventions.


Infection control The single-use sensor head helps to manage the


burden of disinfection and infection control. Recent data achieved using BBI’s current SEM


Scanner includes:


• •


Mersey Care NHS Foundation Trust: year to date the trust is forecasting the number of STEIS reportable category 3 and 4 to be 29% lower than 2018/19


Chelsea & Westminster NHS Foundation Trust: For 87% of patients, nurses reported that the SEM delta had changed their clinical decision making and 89% of patients received additional interventions on the basis of SEM delta readings


For additional information, visit www.sem-scanner.com. 40 Ability Needs Magazine


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48